retatrutide ly3437943 triple agonist gip glp-1 glucagon Structural insights into the agonism at GLP-1R, GIPR and GCGR manifested by retatrutide mechanism triple agonist glp-1

Retatrutide, the newest type of weight-loss drug, helped people lose an average of 70 pounds or about 30% of their body weight over 80 weeks, according to study data from the drugs manufacturer

In the context of GLP-1 receptor biology, where chronic high-level receptor activation can lead to tachyphylaxis (reduced responsiveness over time), partial agonism could potentially maintain a more sustained therapeutic effect over extended treatment periods

Its also considered a good supplement to use in conjunction with in vitro fertilization to support ovarian reserve 22 or how many eggs are available for fertilization

Tissue distribution and integrated pharmacokinetic properties of major effective constituents of oral gegen-qinlian decoction in mice